[1] 王卫理,范晓芳,丁勇俊,等.彩色多普勒超声评价乳腺癌新辅助化疗疗效的临床价值[J].南京医科大学学报,2013,33(6):827~828. [2] 张林,郝洁,王立平,等.乳腺超声造影、彩色多普勒超声及磁共振灌注成像在评估乳腺癌新辅助化疗疗效中的对比研究[J].华中科技大学学报,2014,43(4):449~450. [3] 刘锋,张艳,陈洋,等.彩色多普勒超声在乳腺癌新辅助化疗疗效评价中价值[J].中华实用诊断与治疗杂志,2014,28(10):1017~1018,1021. [4] S Guerriero,J L Alcazar,M A Pascual, et al.Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor.[J].Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,2012,39(5):581~586. [5] 寿俊婷.彩色多普勒超声在乳腺癌新辅助化疗疗效评估中的应用价值[J].浙江中西医结合杂志,2015,25(11):1034~1035. [6] 张彦,陈翠京,史秀云,等.超声检查早期评价乳腺癌新辅助化疗疗效的临床研究[J].临床肿瘤学杂志,2015,20(10):926~927.
2018, Vol. 24 
冀公网安备13080202000677号